Armata Pharmaceuticals, Inc.
ARMP · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$18,916 | -$69,045 | -$36,917 | -$23,155 |
| Dep. & Amort. | $1,325 | $972 | $892 | $1,169 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,893 | $938 | $0 | $2,882 |
| Change in WC | -$2,099 | -$9,646 | $439 | -$3,223 |
| Other Non-Cash | -$20,754 | $29,358 | $3,105 | -$1,248 |
| Operating Cash Flow | -$37,551 | -$47,423 | -$32,481 | -$23,575 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,879 | -$8,144 | -$2,211 | -$1,304 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $10 | $0 | $0 |
| Investing Cash Flow | -$1,879 | -$8,134 | -$2,211 | -$1,304 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $34,889 | $54,026 | $0 | $0 |
| Stock Issued | $130 | $5 | $44,516 | $26,319 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$61 | -$43 | -$500 | -$801 |
| Financing Cash Flow | $34,958 | $53,988 | $44,016 | $25,518 |
| Forex Effect | $0 | $0 | -$4,760 | $0 |
| Net Chg. in Cash | -$4,472 | -$1,569 | $4,564 | $639 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $19,243 | $20,812 | $10,288 | $10,849 |
| End Cash | $14,771 | $19,243 | $14,852 | $11,488 |
| Free Cash Flow | -$39,430 | -$55,567 | -$34,692 | -$24,879 |